Supernus Pharmaceuticals | Bruttoavancen På Salg



Gross Profit On Sales Lave om Dato
Abbott USD 6.03B 93M 2024-12
ANI Pharmaceuticals USD 110.29M 134.46M 2024-12
Aurora Cannabis CAD 9.35M 6.18M 2024-12
Bristol-Myers Squibb USD 9.13B 94M 2024-12
Canopy Growth CAD 24.1M 2.26M 2024-12
Corcept Therapeutics USD 178.93M 745K 2024-12
Eisai JPY 170.21B 16.72B 2024-12
Eli Lilly USD 11.13B 1.86B 2024-12
Indivior 248M 1000K 2024-09
Novo Nordisk 60B 2.22B 2024-09
Pacira USD 147.37M 17.66M 2024-12
Perrigo USD 385.9M 18.5M 2024-12
Pfizer USD 12.11B 718M 2024-12
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
United Therapeutics USD 660M 5.8M 2024-12
Xeris Pharmaceuticals USD 40.67M 400K 2024-09



Supernus Pharmaceuticals Bruttoavancen På Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.